Tag: FDA inspection China India
China and India Manufacturing: Risks and FDA Monitoring in Pharma Supply Chains
China and India dominate global pharmaceutical manufacturing, but FDA inspections reveal stark differences in compliance. India leads in regulatory reliability, while China offers scale - but with higher risk. Here’s what you need to know about drug safety and supply chain vulnerabilities.